Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation | Zendy

Francisco M. Marty | Zendy; Per Ljungman | Zendy; Roy F. Chemaly | Zendy; Johan Maertens | Zendy; Sanjeet Dadwal | Zendy; Rafael F. Duarte | Zendy; Shariq Haider | Zendy; Andrew J. Ullmann | Zendy; Yuta Katayama | Zendy; Janice Brown | Zendy; Kathleen M. Mullane | Zendy; Michael Boeckh | Zendy; Emily A. Blumberg | Zendy; Hermann Einsele | Zendy; David R. Snydman | Zendy; Yoshinobu Kanda | Zendy; Mark J. DiNubile | Zendy; Valerie Teal | Zendy; Hong Wan | Zendy; Yoshihiko Murata | Zendy; Nicholas A. Kartsonis | Zendy; Randi Y. Leavitt | Zendy; Cyrus Badshah | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

Author(s) -

Francisco M. Marty,

Per Ljungman,

Roy F. Chemaly,

Johan Maertens,

Sanjeet Dadwal,

Rafael F. Duarte,

Shariq Haider,

Andrew J. Ullmann,

Yuta Katayama,

Janice Brown,

Kathleen M. Mullane,

Michael Boeckh,

Emily A. Blumberg,

Hermann Einsele,

David R. Snydman,

Yoshinobu Kanda,

Mark J. DiNubile,

Valerie Teal,

Hong Wan,

Yoshihiko Murata,

Nicholas A. Kartsonis,

Randi Y. Leavitt,

Cyrus Badshah

Publication year - 2017

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1706640

Subject(s) - medicine , hematopoietic cell , hematopoietic stem cell transplantation , transplantation , cytomegalovirus , virology , cytomegalovirus infections , haematopoiesis , immunology , intensive care medicine , oncology , human cytomegalovirus , virus , viral disease , herpesviridae , stem cell , biology , genetics

Cytomegalovirus (CMV) infection remains a common complication after allogeneic hematopoietic-cell transplantation. Letermovir is an antiviral drug that inhibits the CMV-terminase complex.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research